Latest News
-
Monday - February 18, 2013
New polycarbodiimide crosslinker supports long pot life
Innovative adhesive technology for films and textile fabrics » more
-
Wednesday - February 13, 2013
Not intended for U.S. and UK Media - Castration-Resistant Prostate Cancer with Bone Metastases:
Radium-223 Dichloride Granted Priority Review by U.S. FDA » more
-
Monday - February 11, 2013
Not intended for U.S. and UK media
Bayer’s Riociguat for Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension Submitted For Regulatory Approval in the U.S. and EU
Riociguat is the first drug that has consistently demonstrated efficacy in two life-threatening PH indications – chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) » more
-
Thursday - February 7, 2013
European Innovative Medicines Initiative (IMI):
Bayer supports innovative drug discovery in Europe
Bayer HealthCare to coordinate international consortium “European Lead Factory” aiming at jointly discovering new medicines » more
-
Wednesday - February 6, 2013
Bayer CropScience at the Fruit Logistica 2013 in Berlin:
Food Chain Partnerships continue to grow worldwide » more
-
Wednesday - February 6, 2013
Bayer MaterialScience at the European Coatings Show 2013
“Leading in Polyurethanes” » more
-
Tuesday - February 5, 2013
Not intended for U.S. and UK Media
Xarelto® to be Studied with Factor Xa Inhibitor Antidote
Bayer and Janssen announce clinical collaboration agreement with Portola » more
-
Tuesday - February 5, 2013
Hands-on science for all:
World tour to mark 150 Years of Bayer
From São Paulo to Shanghai: Bayer AG sends interactive exhibition around the world » more
-
Friday - February 1, 2013
Not intended for U.S. and UK media - IMCAS Congress 2013
Positive results of Phase-III trials suggest that ATX-101 is effective as a non-surgical treatment for the reduction of unwanted submental fat » more
-
Thursday - January 31, 2013
Is Europe heading for a set-back in agriculture?
Bayer CropScience strongly disagrees with proposal by EU Commission
Company asks EU Member States to apply proportionality principles » more
-
Tuesday - January 29, 2013
Bayer CropScience CEO at a high-level stakeholder event in Berlin:
Liam Condon: “Innovation and partnerships needed to achieve food security”
Public-private-partnerships are key to help enhance food security / “Asian German Better Rice Initiative” to improve rice production / A “Greener Revolution” can help drive sustainable agriculture » more
-
Friday - January 25, 2013
Bayer foundation cooperates with Humboldt Foundation
EUR 3 million for new Humboldt-Bayer research fellowships
Financing for 10 post-doctoral fellowships a year through 2018 / Focus on the life sciences, chemistry and pharmacy » more
-
Wednesday - January 23, 2013
Dr. Jörg Reinhardt to leave Bayer HealthCare » more
-
Tuesday - January 22, 2013
Bayer CropScience at the 2nd AGCO Africa Summit in Berlin, Germany:
Bayer: Committed to help raise agricultural productivity in Africa
Need for sustainable introduction of modern technologies / Smallholder farmers key to increase agricultural productivity » more
-
Monday - January 21, 2013
Further milestone towards building a leading biologics technology platform:
Bayer CropScience completes acquisition of Prophyta GmbH » more
-
Monday - January 21, 2013
Not intended for U.S. media - Eight months protection for cats and dogs with only one application:
Bayer Launches New Flea- and Tick-Collar Seresto™ in the U.S.
Innovative collar already successfully introduced in Europe and New Zealand » more
-
Saturday - January 19, 2013
New Bayer CropScience CEO addresses the Global Forum for Food and Agriculture:
Condon: “We need a Greener Revolution in Agriculture”
Five-point plan to drive greater sustainability in farming / Call to public and private stakeholders to join forces » more
-
Thursday - January 17, 2013
Dr. Thomas Steckenreiter to become head of Operation Support & Safety at Bayer Technology Services
Dr. Norbert Kuschnerus to retire » more
-
Thursday - January 17, 2013
Not intended for U.S. and UK Media - Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI) 2013:
Data for Bayer’s Stivarga® (regorafenib) to be Presented at 2013 ASCO-GI Congress
New analyses from the Phase III CORRECT study of regorafenib in the treatment of metastatic colorectal cancer to be presented / Phase I study in hepatocellular carcinoma with regorafenib to be presented » more
-
Wednesday - January 16, 2013
EFSA reports do not change the validity of existing safety data:
Bayer CropScience remains convinced that neonicotinoids can be used safely and effectively in sustainable agriculture
The company is ready to engage further in dialogue » more
Copyright @ Bayer AG
Search
Publications
research – The Bayer Scientific Magazine
Stockholders' Newsletter
Annual Report
Sustainable Development Report
Publications Overview
Newsletter
Events
Download Center - Selection
Bayer TV